[go: up one dir, main page]

EA199800753A1 - Бензотиофены, составы их содержащие и способы с их использованием - Google Patents

Бензотиофены, составы их содержащие и способы с их использованием

Info

Publication number
EA199800753A1
EA199800753A1 EA199800753A EA199800753A EA199800753A1 EA 199800753 A1 EA199800753 A1 EA 199800753A1 EA 199800753 A EA199800753 A EA 199800753A EA 199800753 A EA199800753 A EA 199800753A EA 199800753 A1 EA199800753 A1 EA 199800753A1
Authority
EA
Eurasian Patent Office
Prior art keywords
benzotiophenes
compositions
methods
international
invention proposes
Prior art date
Application number
EA199800753A
Other languages
English (en)
Other versions
EA000767B1 (ru
Inventor
Джордж Дж. Каллинан
Алан Д. Палкович
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9604912.7A external-priority patent/GB9604912D0/en
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA199800753A1 publication Critical patent/EA199800753A1/ru
Publication of EA000767B1 publication Critical patent/EA000767B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Изобретением предлагаются новые соединения бензотиофена.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199800753A 1996-02-22 1997-02-19 Бензотиофены, составы, их содержащие, и способы с их использованием EA000767B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1204496P 1996-02-22 1996-02-22
GBGB9604912.7A GB9604912D0 (en) 1996-03-08 1996-03-08 Benzothiophenes, formulations containing same, and methods
PCT/US1997/002464 WO1997030709A1 (en) 1996-02-22 1997-02-19 Benzothiophenes, formulations containing same, and methods

Publications (2)

Publication Number Publication Date
EA199800753A1 true EA199800753A1 (ru) 1999-02-25
EA000767B1 EA000767B1 (ru) 2000-04-24

Family

ID=26308887

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800753A EA000767B1 (ru) 1996-02-22 1997-02-19 Бензотиофены, составы, их содержащие, и способы с их использованием

Country Status (23)

Country Link
EP (1) EP0791591B1 (ru)
JP (1) JP2000505455A (ru)
KR (1) KR19990087091A (ru)
CN (1) CN1211921A (ru)
AR (2) AR005969A1 (ru)
AT (1) ATE204869T1 (ru)
AU (1) AU713204B2 (ru)
BR (1) BR9707657A (ru)
CA (1) CA2246721A1 (ru)
CO (1) CO4761064A1 (ru)
CZ (1) CZ260798A3 (ru)
DE (1) DE69706338T2 (ru)
DK (1) DK0791591T3 (ru)
EA (1) EA000767B1 (ru)
ES (1) ES2162196T3 (ru)
IL (1) IL125863A (ru)
NO (1) NO983802D0 (ru)
NZ (1) NZ331461A (ru)
PL (1) PL328832A1 (ru)
PT (1) PT791591E (ru)
TR (1) TR199801612T2 (ru)
WO (1) WO1997030709A1 (ru)
YU (1) YU6797A (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001517664A (ja) * 1997-09-23 2001-10-09 イーライ・リリー・アンド・カンパニー ベンゾチオフェン類
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6060488A (en) * 1998-09-22 2000-05-09 Eli Lilly And Company Benzothiophenes for treating estrogen deficiency
MXPA03004398A (es) * 2000-12-05 2003-09-05 Hoffmann La Roche Derivados de benzofurano y benzotiofeno.
EP1530470B9 (en) * 2002-07-22 2010-04-07 Eli Lilly And Company Selective estrogen receptor modulators containing a phenylsulfonyl group
EP1782810A3 (en) * 2002-07-22 2007-05-23 Eli Lilly & Company Selective estrogen receptor modulators containing a phenylsulfonyl group
EP1832582A1 (en) 2002-09-30 2007-09-12 A/S GEA Farmaceutisk Fabrik Novel raloxifene malonic acid addition salts and/or solvates thereof, and pharmaceutical compositions comprising these
NZ541126A (en) * 2003-02-25 2008-07-31 Lilly Co Eli Crystalline non-solvated 1-(4-(2-piperidinylethoxy)phenoxy)-2-(4-methanesulfonylphenyl)-6-hydroxynaphthalene hydrochloride
EP1713770A1 (en) * 2004-01-29 2006-10-25 Eli Lilly And Company Selective estrogen receptor modulators
GR1005694B (el) * 2005-06-08 2007-10-22 Αλεξης Μιχαηλ Ιστοειδικα αντιοιστρογονα ειδικα για τον αλφα υποδοχεα των οιστρογονων
CN111018770A (zh) * 2019-12-26 2020-04-17 北京鑫开元医药科技有限公司 一种巴多昔芬氧化物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL65404A0 (en) * 1981-04-03 1982-07-30 Lilly Co Eli Benzothiophene compounds and process for preparing them
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US6756388B1 (en) * 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US5510357A (en) * 1995-02-28 1996-04-23 Eli Lilly And Company Benzothiophene compounds as anti-estrogenic agents

Also Published As

Publication number Publication date
CN1211921A (zh) 1999-03-24
AU713204B2 (en) 1999-11-25
CO4761064A1 (es) 1999-04-27
EP0791591A1 (en) 1997-08-27
IL125863A (en) 2000-10-31
EP0791591B1 (en) 2001-08-29
PT791591E (pt) 2001-12-28
WO1997030709A1 (en) 1997-08-28
NO983802L (no) 1998-08-19
IL125863A0 (en) 1999-04-11
NO983802D0 (no) 1998-08-19
DE69706338T2 (de) 2002-06-13
KR19990087091A (ko) 1999-12-15
ATE204869T1 (de) 2001-09-15
JP2000505455A (ja) 2000-05-09
NZ331461A (en) 1999-05-28
CZ260798A3 (cs) 1999-05-12
AR005970A1 (es) 1999-07-21
BR9707657A (pt) 1999-07-27
DK0791591T3 (da) 2001-10-08
YU6797A (sh) 1999-09-27
ES2162196T3 (es) 2001-12-16
EA000767B1 (ru) 2000-04-24
PL328832A1 (en) 1999-02-15
AR005969A1 (es) 1999-07-21
TR199801612T2 (xx) 1998-11-23
DE69706338D1 (de) 2001-10-04
CA2246721A1 (en) 1997-08-28
AU2276497A (en) 1997-09-10

Similar Documents

Publication Publication Date Title
EA200100773A1 (ru) Замещенные 1-гетероциклические диариламины
EA199900325A1 (ru) Форма d дигидрата оланзапина
EA199800667A1 (ru) Новые фенантридины
FI20095804A7 (fi) Bentsotiofeeniyhdisteet, välituotteet, koostumukset ja menetelmät
ES2195970T3 (es) L-ribavirina y usos de la misma.
EA199800857A1 (ru) Композиция для снятия боли и способ снятия боли
EA200100022A1 (ru) Композиции с контролируемым высвобождением пароксетина
BG99177A (bg) Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза
EA200001039A1 (ru) Кальцилитические соединения
EA199900362A1 (ru) Новые соединения, полезные для использования в качестве нейрозащитных средств
AR016981A2 (es) Polipeptidos sinteticos
EA199800753A1 (ru) Бензотиофены, составы их содержащие и способы с их использованием
EA199800867A1 (ru) Соединения тетрагидробетакарболина
BR9916507A (pt) Proteìnas
EA200100854A1 (ru) Кальций-литические соединения
EA200000884A1 (ru) Производные стрептограминов, их получение и содержащие их композиции
FI962323L (fi) N-substituoidut atsabisykloheptaanijohdannaiset, kuten esim. neuroleptit
DK0929299T3 (da) Substituerede 1,2,3,4-tetrahydro-2-dibenzofuranaminer og 2-aminocyclohepta-(b)benzofuraner
EA199900534A1 (ru) Имидазопиридазины
EA199900235A1 (ru) Аморфные бензотиофены, способы получения и способы применения
EA200400670A1 (ru) Фармацевтические композиции, содержащие 3,4-пропинопергидропурины, и их применение для блокирования нейронной передачи
EA200200798A1 (ru) Кальцилитические соединения
ITTO970975A0 (it) Composizioni organiche.
EA200000365A1 (ru) Полиморфные модификации дофетилида
DE3873278D1 (de) Aryl-substituierte thiophen-3-ole, ihre derivate und analoge als lipoxygenase-inhibitoren.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU